Migrevention Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $321K

  • Investors
  • 7

Migrevention General Information

Description

Developer of digital clinical management software designed for primary headache care. The company's platform combines a clinically validated patient-facing medical technology with provider management tools, including digital headache diaries, symptom and trigger tracking, secure data sharing, and aggregated data capabilities, enabling patients to improve understanding, coordination, and efficiency of headache diagnosis, treatment, and disease management.

Contact Information

Website
www.migrevention.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Mõisavahe 34b
  • Tartu, 50708
  • Estonia
+372 529
Primary Industry
Other Healthcare Technology Systems
Vertical(s)
Digital Health
Corporate Office
  • Mõisavahe 34b
  • Tartu, 50708
  • Estonia
+372 529

Migrevention Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Migrevention Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Seed Round 08-Dec-2025 $321K Completed Generating Revenue
6. Accelerator/Incubator Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
4. Angel (individual) 05-Oct-2021 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
1. Grant 01-Jan-2020 $27.8K Completed Generating Revenue
To view Migrevention’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Migrevention Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of digital clinical management software designed for primary headache care. The company's platform combines a
Other Healthcare Technology Systems
Tartu, Estonia
8 As of 2026

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Migrevention Competitors (1)

One of Migrevention’s competitors is Neura Health, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neura Health Venture Capital-Backed New York, NY
You’re viewing 1 of 1 competitors. Get the full list »

Migrevention Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Migrevention Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Verge Capital Management Venture Capital Minority
StartSmart CEE Accelerator/Incubator
Angel (individual) Minority
Challenger Accelerator Accelerator/Incubator
Ajujaht Accelerator/Incubator
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Migrevention FAQs

  • When was Migrevention founded?

    Migrevention was founded in 2020.

  • Where is Migrevention headquartered?

    Migrevention is headquartered in Tartu, Estonia.

  • What is the size of Migrevention?

    Migrevention has 8 total employees.

  • What industry is Migrevention in?

    Migrevention’s primary industry is Other Healthcare Technology Systems.

  • Is Migrevention a private or public company?

    Migrevention is a Private company.

  • What is Migrevention’s current revenue?

    The current revenue for Migrevention is .

  • How much funding has Migrevention raised over time?

    Migrevention has raised $737K.

  • Who are Migrevention’s investors?

    Verge Capital Management, StartSmart CEE, , Challenger Accelerator, and Ajujaht are 5 of 7 investors who have invested in Migrevention.

  • Who are Migrevention’s competitors?

    Neura Health is a competitor of Migrevention.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process